Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Details)

v3.19.1
Segment Information (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Mar. 31, 2019
Mar. 25, 2018
Mar. 31, 2019
Mar. 25, 2018
Sep. 30, 2018
Segment Reporting Information [Line Items]          
Segment reporting, factors used to identify entity's reportable segments     We are organized on the basis of products and services and have three reportable segments.    
Revenues $ 4,982 $ 5,220 $ 9,824 $ 11,255  
EBT 806 317 1,366 258  
Total assets 34,023   34,023   $ 32,718
Cost of revenues (2,179) (2,239) (4,367) (4,902)  
Research and development expense (1,308) (1,402) (2,577) (2,822)  
Selling, general and administrative expense (573) (869) (1,100) (1,641)  
Other expenses 18 (310) (130) (1,493)  
Interest expense (162) (179) (317) (350)  
Investment and other income, net 28 96 33 211  
Reconciling Items [Member]          
Segment Reporting Information [Line Items]          
Revenues 40 74 97 162  
EBT (427) (1,140) (1,063) (3,020)  
Total assets 27,277   27,277   26,926
Cost of revenues (104) (111) (218) (228)  
Research and development expense (190) (271) (337) (551)  
Selling, general and administrative expense (84) (258) (148) (420)  
Other expenses 18 (310) (130) (1,493)  
Interest expense (159) (179) (313) (348)  
Investment and other income, net 109 82 130 206  
Reconciling Items [Member] | Cost of revenues [Member]          
Segment Reporting Information [Line Items]          
Unallocated acquisition-related expenses 99 102 202 208  
Reconciling Items [Member] | Research and development expenses [Member]          
Segment Reporting Information [Line Items]          
Unallocated acquisition-related expenses 1 2 2 3  
Reconciling Items [Member] | Selling, general and administrative expenses [Member]          
Segment Reporting Information [Line Items]          
Unallocated acquisition-related expenses 7 214 $ 14 290  
Corporate, Non-Segment [Member] | Reconciling Items [Member]          
Segment Reporting Information [Line Items]          
Segment reporting, change in measurement methods     In fiscal 2018, all of the costs related to pre-commercial research and development of 5G technologies, of which we recorded $115 million and $216 million in the second quarter and first six months of fiscal 2018, respectively, were included in unallocated corporate research and development expenses. Beginning in the first quarter of fiscal 2019, all research and development costs associated with 5G technologies are included in segment results.    
Change of Segment Methodology [Member] | Reconciling Items [Member]          
Segment Reporting Information [Line Items]          
Research and development expense 115   $ 216    
QCT [Member]          
Segment Reporting Information [Line Items]          
Segment reporting, change in measurement methods     During the first quarter of fiscal 2019, we combined our Small Cells business, which sells products designed for the implementation of small cells to address the challenge of meeting the increased demand for mobile data, into our QCT segment. Revenues and operating results related to the Small Cells business were included in nonreportable segments through the end of fiscal 2018. Prior period segment information has not been adjusted to conform to the new segment presentation as such adjustments are insignificant.    
Revenues 3,722 3,897 $ 7,461 8,548  
EBT 542 608 1,140 1,563  
Total assets 2,948   $ 2,948   3,041
QTL [Member]          
Segment Reporting Information [Line Items]          
Segment reporting, change in measurement methods     Additionally, beginning in the first quarter of fiscal 2019, certain research and development costs associated with early research and development that were historically included in our QCT segment are allocated to our QTL segment. The net effect of these changes negatively impacted QTL’s EBT by $119 million and $241 million in the second quarter and first six months of fiscal 2019, respectively. QCT's EBT was positively impacted by $32 million and $44 million in the second quarter and first six months of fiscal 2019, respectively.    
Revenues 1,122 1,219 $ 2,141 2,485  
EBT 674 809 1,264 1,664  
Total assets 2,405   2,405   1,472
QSI [Member]          
Segment Reporting Information [Line Items]          
Revenues 98 30 125 60  
EBT 17 40 25 51  
Total assets 1,393   1,393   $ 1,279
Other Segments [Member]          
Segment Reporting Information [Line Items]          
Revenues 40 74 97 162  
EBT (17) $ (93) (47) $ (186)  
Impact to QTL Segment EBT due to Segment Methodology Change [Member]          
Segment Reporting Information [Line Items]          
EBT (119)   (241)    
Impact to QCT Segment EBT due to Segment Methodology Change [Member]          
Segment Reporting Information [Line Items]          
EBT $ 32   $ 44